Illumina, Inc.
NASDAQIllumina heads into its October 30 earnings with a sharp divergence at its core: short sellers have been covering steadily for weeks, yet options traders turned their most defensive in a year on the very day the stock fell nearly 7%. The short-selling picture is unambiguously improving. Short interest in Illumina has dropped 12.5% over the past week to 5.8% of the free float, a…
ILMN UBS upgrades to Buy with $260 target, implying 23% upside from $211 close. Prior rating was Neutral at $135 target.
Illumina heads into its October 30 earnings with a sharp divergence at its core: short sellers have been covering steadily for weeks, yet options traders turned their most defensive in a year on the very day the stock…
Illumina heads into the week of September 15 with a striking internal contradiction: the Street's consensus price target sits below where the stock is already trading, yet the most influential analyst move in months…
Snapshot as of 7 Oct 2026
Illumina heads into the first week of September with a story that has shifted materially since last week's note — short sellers are now pulling back, but the director who sold aggressively into late-August strength is…
Illumina enters the final stretch of August with a striking divergence: short sellers are piling in at the fastest pace in months, while a board-linked insider was simultaneously selling tens of millions of dollars…
ILMN closes out June in an unusual place: short sellers have now added roughly 38% to their positions over the past month, yet the Street's analyst community spent the final week of June racing to lift price targets —…
ILMN heads into the final week of June with a striking divergence: options traders are the most bullishly positioned they've been in over a year, while short sellers have spent the past month quietly adding exposure —…
Illumina enters the week with its most consequential analyst upgrade in months arriving just as the stock slips back from recent highs — and with the two loudest institutional voices on the name now pointing in…
Illumina has rallied 20% in a month. The loudest response has come not from bulls adding to positions, but from a board-level insider selling tens of millions of dollars into the strength. Keith Meister — who controls…
Illumina enters its May 21 earnings call with an unusual setup: shorts are quietly exiting a stock that just posted a blowout quarter, while options traders are near the most defensive they've been all year. The…
Illumina reports Q1 2026 results today after the close, arriving at the print already beaten up — down 7.8% on the week and 5.2% on Wednesday alone, with two consecutive double-digit post-earnings drops in recent…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ILMN — free to start on ORTEX.
Sign up for free →Open ILMN on ORTEX